Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha
about
Open access chemical probes for epigenetic targetsLP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorLP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorGene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer.Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material.Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: a genome-wide follow-up study.High-resolution genomic profiling of human papillomavirus-associated vulval neoplasia.GAB2 amplifications refine molecular classification of melanoma.A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines.DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification.Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis.Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma.Enriched environment inhibits mouse pancreatic cancer growth and down-regulates the expression of mitochondria-related genes in cancer cells.Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?Genetic variation in DROSHA 3'UTR regulated by hsa-miR-27b is associated with bladder cancer risk.Regulation of cellular miRNA expression by human papillomaviruses.Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples.An Optimization-Driven Analysis Pipeline to Uncover Biomarkers and Signaling Paths: Cervix Cancer.Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism.Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival.Regulation of microRNA processing in development, differentiation and cancer.An overview of hepatocellular carcinoma study by omics-based methods.Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation.MicroRNAs and their role in gynecological tumors.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.FHACT: the FISH-based HPV-associated cancer test that detects nonrandom gain at four genomic loci as biomarkers of disease progression.Identifying key nodes in multilayer networks based on tensor decomposition.Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness.Epigenetic Alterations in Human Papillomavirus-Associated Cancers.Biological function and histone recognition of family IV bromodomain-containing proteins.Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer.Altered JS-2 expression in colorectal cancers and its clinical pathological relevance.Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles.9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomainPerturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.Scattered genomic amplification in dedifferentiated liposarcoma.
P2860
Q26781872-E1389A1E-D2B2-45CB-9698-4A3C86F69B94Q28260305-C94CC13D-CC84-4485-A754-C247EAAC0793Q28834025-33531BC9-A6F0-4418-A9D5-547E381E598BQ30884181-A84A60FD-64ED-496E-AB04-FAC0FEEE23D2Q33612207-2E2C6B75-24E3-48DA-B2EE-467F34F6A1A0Q33690029-7ECFD3D2-0AD1-434A-9B06-09736C4D4ED7Q33747413-26F9BF7C-EB95-4694-9A2F-570332AC648CQ33883923-9F641828-849F-474E-B233-7845064CDA8FQ34049716-B649384A-DB59-4C2F-8AA2-8B42F5CFB3C8Q34121517-E124A66F-BD66-463B-B124-9AACEA7EC571Q34193299-F570C278-46BC-4E55-89E4-5A78EE9DBF4FQ34203095-54CB7732-0372-4852-832A-FA33406D4F11Q34569934-A8C45F64-B944-49EE-B505-7A46D42FF7E7Q34658788-C6ABA990-1741-4D2C-9F41-724789FC4E71Q34891045-CDB4A107-0042-43BA-9DD5-16ECB5BBEDF2Q34980981-F1402AAA-C802-4298-90D3-29C98DF70D8BQ34997163-85335F9E-8945-447B-9839-77B259FD95D7Q35060569-624AEC54-66EA-4DD7-998C-040244198628Q35219098-F5719B85-4B89-40AC-89CB-7165F3BC22EBQ35772988-90D00BF0-771C-43B7-A275-EE628F35251BQ36069642-3AE9F51F-95AD-444D-BBBB-1F8E2F79EC94Q36197642-C80D2EC4-92E4-48EE-9283-9670FD75890CQ36333354-6E25ABB9-701B-4BD1-B0B9-AF76B90DB63FQ37100743-7ABDAD7C-B9E1-4353-A8C3-2E9DD5F07C0AQ37110886-B87B7DFB-13C3-4288-ADAB-0231C4D387EDQ37364456-451BC6E5-51E1-40C3-93A5-8F5FA3D1D753Q37536775-01F207D5-13ED-4A2F-B2B7-4718C8AEBC50Q37722649-F3D0A011-DAB1-4489-87B6-A0D16563E54EQ38258014-B98317D0-5EA2-40D9-B21C-D3666B8A5166Q38259453-D733692E-D59A-4A4C-B49C-ABCC9BBAF466Q38431655-AF373B38-2FDB-45C4-AADD-C86A374465C8Q38500553-9F21AEE5-B54B-43B0-966E-77D99D56BF29Q38598051-498F415C-11C6-4EDD-B092-CADDE8D3465EQ38788315-7163934F-FB61-40EE-A3BC-5CE8F713FCF5Q38821651-36F02B04-4514-4782-A00C-C7FF3F8677D0Q39498261-6576490D-098D-4A58-AEA6-588AA378B5E9Q39540562-00EDEAD0-FF56-43A8-99B8-112CD18F9414Q39809867-446FA89E-069D-4012-BB59-68CB25B779B9Q40225237-CFFEA804-3C6A-447A-9B23-EA88AF72041CQ41051350-0BBF343F-6E8F-4459-9308-1D15855B0288
P2860
Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Integrative genomics analysis ...... ressed genes, including Drosha
@ast
Integrative genomics analysis ...... ressed genes, including Drosha
@en
Integrative genomics analysis ...... ressed genes, including Drosha
@en-gb
Integrative genomics analysis ...... ressed genes, including Drosha
@nl
type
label
Integrative genomics analysis ...... ressed genes, including Drosha
@ast
Integrative genomics analysis ...... ressed genes, including Drosha
@en
Integrative genomics analysis ...... ressed genes, including Drosha
@en-gb
Integrative genomics analysis ...... ressed genes, including Drosha
@nl
prefLabel
Integrative genomics analysis ...... ressed genes, including Drosha
@ast
Integrative genomics analysis ...... ressed genes, including Drosha
@en
Integrative genomics analysis ...... ressed genes, including Drosha
@en-gb
Integrative genomics analysis ...... ressed genes, including Drosha
@nl
P2093
P2860
P3181
P356
P1433
P1476
Integrative genomics analysis ...... ressed genes, including Drosha
@en
P2093
Achim Schneider
Andreas M Kaufmann
Bhavana Pothuri
Gopeshwar Narayan
Jason D Wright
Luigi Scotto
Mahesh Mansukhani
Shivakumar Subramaniyam
Subhadra V Nandula
Vundavalli V Murty
P2860
P2888
P3181
P356
10.1186/1476-4598-7-58
P407
P577
2008-06-17T00:00:00Z
P5875
P6179
1007405477